ReviewJournal of thoracic disease2018
Screening for early stage lung cancer and its correlation with lung nodule detection.
Review in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05481762 (Evaluation of Computer-Aided Lung Nodule Detection Software in Chest CT Scans With an Assessment of Its Impact on Readers Decision-Making Process), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Computer-Aided Lung Nodule Detection Software in Chest CT Scans With an Assessment of Its Impact on Readers Decision-Making Process
Who cites it
14 citing papers in PubMed, 26 citations in OpenAlex.
- Automated diagnosis of pulmonary nodules in 3D PET/CT images using dual-path densely connected networks with cross-modal fusion.Quantitative imaging in medicine and surgery · 2026Article
- USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway.Oncogenesis · 2024Article
- Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review.Cancers · 2024Review
- Gut microbes as medical signature for the effectiveness of immunotherapy in patients with advanced non-small cell lung cancer.Aging medicine (Milton (N.S.W)) · 2024Review
- Classification of Pulmonary Nodules in 2-[Nuclear medicine and molecular imaging · 2024Article
- Qualitative (and Quantitative) Values of the Lung-RADS and Computed Tomography in Diagnosing Solitary Pulmonary Nodules.Diagnostics (Basel, Switzerland) · 2022Article
- Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation.Oxidative medicine and cellular longevity · 2021Review
- Reduced expression of circRNA novel_circ_0005280 and its clinical value in the diagnosis of non-small cell lung cancer.Journal of thoracic disease · 2020Article
- Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.Journal of thoracic disease · 2020Article
- A Task-dependent Investigation on Dose and Texture in CT Image Reconstruction.IEEE transactions on radiation and plasma medical sciences · 2020Article
- Evaluating the efficacy of bronchoscopy for the diagnosis of early stage lung cancer.Journal of thoracic disease · 2020Review
- hsa_circRNA_012515 Is Highly Expressed in NSCLC Patients and Affects Its Prognosis.Cancer management and research · 2020Article
- Spiral wire localization of lung nodules: procedure effectiveness and oncological usefulness.Journal of thoracic disease · 2019Article
- Volumetric assessment of solid pulmonary nodules on ultralow-dose CT: a phantom study.Journal of thoracic disease · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, the most effective way of reducing lung cancer mortality is early diagnosis of lung cancer. The National Lung Screening Trial has proved the efficacy of lung cancer screening using low-dose computed tomography to reduce lung cancer mortality. However, many questions remain surrounding lung cancer screening implementation, among which include how to select the optimal risk population, the personalized screening interval based different levels of risk, methods to improve diagnostic discrimination between malignant and benign disease in detected lung nodules, and the roles of biomolecular markers in stratifying risk and in guiding the management of indeterminate nodules. This review concentrates on the latest developments of lung cancer screening and provides an overview of the main unanswered questions on lung nodule detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.